BLRX Latest Press Releases

-- November 24, 2025 --

BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update PRNewswire 7:00 AM

-- November 19, 2025 --

Hemispherian Announces USPTO Notice of Allowance for Key GLIX1 Patent Covering Majority of Solid Tumors Business Wire 3:00 AM

-- November 18, 2025 --

BioLineRx to Report Third Quarter 2025 Results on November 24, 2025 PRNewswire 7:00 AM

-- November 17, 2025 --

BioLineRx Announces Receipt of USPTO Notice of Allowance for Key Patent Covering GLIX1 for Treating a Broad Range of Cancer Types PRNewswire 7:00 AM

-- September 29, 2025 --

BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers PRNewswire 7:01 AM

-- August 31, 2025 --

BioLineRx ADR Earnings Call: Optimism Amid Challenges TipRanks 9:38 PM

-- August 14, 2025 --

BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update PRNewswire 7:00 AM

-- August 7, 2025 --

BioLineRx to Report Second Quarter 2025 Results on August 14, 2025 PRNewswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software